Carlyle picks up 20% stake in Piramal pharma biz for $490 mn
The 20% stake sale values Piramal’s pharma business at Rs 20,000 crore.
Pharma shines in advance tax pay
When it comes to advance tax payments, pharma has emerged as one of the outliers with the sector showing a higher payout this quarter, while real estate, infrastructure, steel and cement were among segments that crumbled under the weight of the coronavirus-induced lockdown.
Government to curb pharma imports from China
Higher duties on Chinese products may also be on the cards, official sources said. These moves gathered pace in the wake of the military face-off between India and China in east Ladakh and the continuing diplomatic tension since then, prompting the government to explore all options to reduce import dependence on China.
Pharma emerges as most preferred sector among MFs
Earnings downgrade in the sector is likely to be the lowest among all sectors.
Share market update: Pharma shares slip; Aurobindo Pharma dips 3%
The Nifty Pharma index was trading 1.03 per cent down at 9151.4 .
Ashish Dhawan goes bargain hunting amid market meltdown
The investments, from Dhawan’s personal investment entities, were done in March last week.
Govt incentives will help Indian pharma cos reduce API imports from China: Tata Mutual Fund
‘We have a very strong presence in the formulation market’
Andhra Pradesh: Two dead, four injured in benzene gas leak at pharma plant in Vizag
Two people were killed and four others were taken ill after benzene gas leaked at a pharmaceutical company at Parawada near here early on Tu...
PI Industries launches QIP to raise Rs 2,000 crore
The QIP has been launched at an indicative price of Rs 1534 per share, about 2% discount to the last closing price of Rs 1562 on July 2, said bankers.
Share market update: Pharma shares advance; Sun Pharma rises 1%
The Nifty Pharma index was trading 0.07 per cent up at 9950.15.
Why are pharma stocks rallying? Surajit Pal explains
‘The US market provides good revenue in dollars which is a bonus’
Roche Pharma India expands partnership with Cipla for key oncology medicines
Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India," the company said in a statement.
ETMarkets Survey: How to invest Rs 1 lakh in a Covid19-hit market
With economic outlook very uncertain, should you still remain heavy on equities?
Share market update: Pharma shares dip; Aurobindo Pharma down 2%
The Nifty Pharma index was trading 0.88 per cent down at 10047.2.
Share market update: Pharma shares gain; Cadila Healthcare climbs 5%
The Nifty Pharma index was trading 1.01 per cent up at 9240.55.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service